WDB coco Co (TSE:7079) Debt-to-Revenue : 0.00 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is WDB coco Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

WDB coco Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円0 Mil. WDB coco Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円0 Mil. WDB coco Co's annualized Revenue for the quarter that ended in Dec. 2023 was 円4,834 Mil. WDB coco Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.00.

WDB coco Co Debt-to-Revenue Historical Data

The historical data trend for WDB coco Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WDB coco Co Debt-to-Revenue Chart

WDB coco Co Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Revenue

Get a 7-Day Free Trial

0.01

WDB coco Co Quarterly Data
	Mar18	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial															-	0.01	-	-	-

Competitive Comparison of WDB coco Co's Debt-to-Revenue

For the Health Information Services subindustry, WDB coco Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WDB coco Co's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, WDB coco Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where WDB coco Co's Debt-to-Revenue falls into.

WDB coco Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

WDB coco Co's Debt-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(11.293	+	13.028)	/	4070.609
	=	0.01

WDB coco Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	4834.26
	=	0.00

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.

WDB coco Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of WDB coco Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

WDB coco Co (TSE:7079) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WDB coco Co Ltd (TSE:7079) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-8-11 Harumi, Chuo-ku, Triton Square Y 27th Floor, Tokyo, JPN, 104-6127

Website

https://www.wdbcoco.com

WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC related work, PMS facility contract support related work, clinical research support / monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments such as monitoring, safety information, data management and statistical analysis. It provides support for the development of generic drugs such as bioequivalence studies and biosimilars, clinical research and physician-led clinical trials.

WDB coco Co (TSE:7079) Headlines

No Headlines